Vanda Pharmaceuticals Inc (VNDA)
4.88
+0.22
(+4.72%)
USD |
NASDAQ |
Nov 04, 12:58
Vanda Pharmaceuticals 1 Year Total Returns (Daily): 6.64% for Nov. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 01, 2024 | 6.64% |
October 31, 2024 | 6.16% |
October 30, 2024 | 5.07% |
October 29, 2024 | 13.01% |
October 28, 2024 | 15.18% |
October 25, 2024 | 6.31% |
October 24, 2024 | 7.11% |
October 23, 2024 | 10.61% |
October 22, 2024 | 8.99% |
October 21, 2024 | 8.99% |
October 18, 2024 | 9.60% |
October 17, 2024 | 5.46% |
October 16, 2024 | 11.11% |
October 15, 2024 | 12.94% |
October 14, 2024 | 13.18% |
October 11, 2024 | -1.77% |
October 10, 2024 | -2.86% |
October 09, 2024 | -0.45% |
October 08, 2024 | -1.97% |
October 07, 2024 | -1.75% |
October 04, 2024 | 7.67% |
October 03, 2024 | 8.96% |
October 02, 2024 | 10.07% |
October 01, 2024 | 5.09% |
September 30, 2024 | 8.56% |
Date | Value |
---|---|
September 27, 2024 | 0.43% |
September 26, 2024 | 4.41% |
September 25, 2024 | 8.99% |
September 24, 2024 | 9.98% |
September 23, 2024 | 5.32% |
September 20, 2024 | 7.71% |
September 19, 2024 | 5.92% |
September 18, 2024 | 10.99% |
September 17, 2024 | 5.11% |
September 16, 2024 | 8.09% |
September 13, 2024 | 7.37% |
September 12, 2024 | 7.08% |
September 11, 2024 | 4.90% |
September 10, 2024 | 7.79% |
September 09, 2024 | 8.66% |
September 06, 2024 | 14.35% |
September 05, 2024 | 13.39% |
September 04, 2024 | -0.59% |
September 03, 2024 | -0.59% |
August 30, 2024 | -1.12% |
August 29, 2024 | -4.74% |
August 28, 2024 | -5.04% |
August 27, 2024 | -4.12% |
August 26, 2024 | -1.61% |
August 23, 2024 | -7.30% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-68.48%
Minimum
Nov 10 2023
127.2%
Maximum
Mar 18 2021
-16.06%
Average
-30.41%
Median
1 Year Total Returns (Daily) Benchmarks
Zevra Therapeutics Inc | 88.76% |
Edgewise Therapeutics Inc | 427.1% |
NovaBay Pharmaceuticals Inc | -93.74% |
Palatin Technologies Inc | -43.13% |
iBio Inc | -49.85% |